Filing Details
- Accession Number:
- 0001179110-19-005746
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-05-08 20:22:28
- Reporting Period:
- 2019-05-07
- Accepted Time:
- 2019-05-08 20:22:28
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1651561 | Tabula Rasa Healthcare Inc. | TRHC | Services-Business Services, Nec (7389) | 465726437 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1685833 | H Calvin Knowlton | 228 Strawbridge Drive Suite 100 Moorestown NJ 08057 | Chief Executive Officer | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2019-05-07 | 3,741 | $52.94 | 900,834 | No | 4 | S | Direct | |
Common Stock | Disposition | 2019-05-07 | 3,529 | $54.09 | 897,575 | No | 4 | S | Direct | |
Common Stock | Disposition | 2019-05-07 | 1,000 | $55.00 | 896,575 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 807,917 | Indirect | Held by spouse. |
Common Stock | 10,000 | Indirect | Held by trust for children. |
Common Stock | 10,000 | Indirect | Held by trust for children. |
Footnotes
- This sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 7, 2018.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $52.42 to $53.31, inclusive. The reporting person undertakes to provide to Tabula Rasa HealthCare, Inc., any security holder of Tabula Rasa HealthCare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the ranges set forth in footnotes (2), (3) and (4) to this Form 4.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $53.58 to $54.56, inclusive.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $54.81 to $55.53, inclusive.
- The reporting person received a restricted stock award of 337,307 shares of the Company's common stock on September 28, 2016. Pursuant to amendments to the restricted stock award on June 12, 2017 and May 30, 2018, respectively, 50% of such shares of common stock were scheduled to vest on May 31, 2019, with the remaining 50% of such shares of common stock scheduled to vest on January 31, 2020. Notwithstanding the foregoing, on May 2, 2019, the Company entered into an amendment to the restricted stock award with the reporting person and, pursuant thereto, all shares of common stock underlying such restricted stock award will now vest in six equal installments at the end of each calendar quarter beginning on June 30, 2019 and ending on September 30, 2020, such that the shares of common stock underlying such restricted stock award will be vested in full on September 30, 2020.